Three federal agencies are seeking comments on the public’s experience with medical payment products, billing and collection practices in a bid to address possible consumer harms caused by these types of specialty credit products.
The Consumer Financial Protection Bureau (CFPB) has teamed up with the Treasury and the Department of Health and Human Services (HHS) to see whether healthcare providers are promoting financial products — like medical credit cards and loans — to pay for healthcare that raise patient debt and lead to higher consumer costs.
The deadline for submitting comments is September 11. Complaints about a host of other financial products or services can also be submitted at CFPB’s website or by calling (855) 411-CFPB (2372).
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The agencies intend to use the comments to provide a better understanding of the prevalence of these products, patients’ experiences with them and the healthcare providers’ incentives to offer these products to patients.
“Financial firms are partnering with healthcare players to push products that can drive patients deep into debt,” said CFPB Director Rohit Chopra. “We are opening a public inquiry to better understand how these practices are affecting patients in our country.”
In a report on patients with medical debt, first published in May, the agencies found that specialty medical payment products, which were once largely used to pay for care not covered by traditional insurance plans such as dental or vision care, are now being used for more services, including emergency room visits. Some of these services are already covered by insurance or financial assistance plans, but healthcare providers are pitching the higher-cost specialty products to patients instead because they can pass the patient billing and collections over to financial services companies, the CFPB said.
From 2018 to 2020, consumers used specialty medical cards or loans with deferred interest periods to pay for nearly $23 billion in healthcare costs, a recent CFPB study revealed. These newer forms of medical debt are typically more expensive for patients than other forms of payment, including conventional credit cards, with interest rates often exceeding 25%, the study showed.
The agencies are seeking more information on a range of concerns for consumers regarding this market, including interest and fee costs of these products and how they are marketed; whether consumers fully understand the risks of using specialty cards; billing and financial assistance issues; as well as how incentives offered to health care providers affect their promotion of these products to patients.
Related stories
-
Visa Is the Worst Dow Stock Wednesday. Here's WhyVisa stock is down sharply Wednesday after the credit card company came up short of revenue expectations for its fiscal Q3.
-
Another Analyst Moves to the Sidelines on Tesla Stock After EarningsTesla stock is spiraling Wednesday after the EV maker's big earnings miss and Wall Street has been quick to weigh in. Here's what you need to know.
-
Biden Has One Last Obamacare Policy To Roll Out: The Kiplinger LetterThe Kiplinger letter This final Obamacare policy would require states to synchronize open enrollment if they operate their own Obamacare exchanges.
-
More Weight-Loss Drugs, Like Ozempic, are in the Works: Kiplinger Economic ForecastsEconomic Forecasts Pharmaceutical companies are developing more weight-loss drugs similar to Ozempic, but these injectables are still expensive.
-
Still Have FSA Money to Spend?Still have FSA money to spend from your healthcare flexible spending account? Here are some ideas to use it up.
-
Amazon launches RxPass — its new subscription service for medicationAmazon's new program, RxPass, lets Prime members ship prescription medications to their homes for just $5 a month.
